The Impact of CAR-T Cell Therapy in Relapsed/Refractory Multiple Myeloma
The paradigm for management of relapsed myeloma is evolving rapidly with a plethora of treatment options based on results of clinical trials. One explosive area of scientific and clinical research is the investigation of chimeric antigen receptor T-cell therapy.
Prescribing TKIs for the Treatment of CML
Pamela Crilley, DO, explains the benefits and downfalls of prescribing tyrosine kinase inhibitors for the treatment of CML.
2 Clarke Drive Cranbury, NJ 08512